Pentamidine sensitizes FDA-approved non-antibiotics for the inhibition of multidrug-resistant Gram-negative pathogens
Chenxuan Wu(Hunan University), Xinxin Feng(Hunan University), Yandong Wu(Hunan University), Kai Zhou(Zunyi Medical University), Yuanxin Gu(Hunan University), Wenyao Li(Sichuan University), Wei Huang(Chinese Academy of Sciences), Chang Liu(Paul Scherrer Institute), Luting Ji(Hunan University), Yangfan Xu(Hunan University), Xia Ling(Hunan University)
European Journal of Clinical Microbiology & Infectious Diseases
April 2, 2020
Cited by 14
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k